MEDRIX is a general practice in Rixensart. Private Limited, started on 10 November 1993.

What is the address of MEDRIX?

The registered office of MEDRIX is located at Clos de la Mare aux Loups 14, 1330 Rixensart.

Is MEDRIX still active?

Yes. According to the CBE (29 October 2026) MEDRIX is active, legal situation “Normale toestand”, started on 10 November 1993.

Is MEDRIX registered on Peppol?

Yes, MEDRIX is registered on the Peppol network with ID 0208:0451444532.

What is the enterprise number of MEDRIX?

The enterprise number of MEDRIX is BE0451444532.

When was MEDRIX founded?

MEDRIX was founded on 10 November 1993.

Who are the directors of MEDRIX?

According to the 2025 annual accounts, the directors of MEDRIX are: Fabienne Boval, Pierre Trefois.

Is MEDRIX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 10 November 1993; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did MEDRIX make in 2025?

MEDRIX posted a profit after taxes of € 15,684 in financial year 2025.

What is the revenue of MEDRIX?

As a small company, MEDRIX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 37,281.

How many employees does MEDRIX have?

According to the 2025 annual accounts, MEDRIX has 0 full-time equivalents (FTE).

MEDRIX (Private Limited) - Rixensart - BE0451444532

Dossier MEDRIX, printed on 29 October 2026 from databakkes.be/en/0451444532/medrix. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDRIX from Rixensart, company number BE0451444532, closed financial year 2025 with a result of € 15,684 after tax. For that financial year MEDRIX recorded a gross margin of € 37,281 and equity of € 378,281. Compared with financial year 2024, the result moved from € 97,002 to € 15,684. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 20, 2026.

What it is worth Growing

€ 378,281

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 15,684

▼ 84% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 195,464

▼ 37% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 372,084.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 17,059

▲ 21% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 740

▼ 21% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 22,735

▼ 6% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 73,574 Gross margin 2022: € 73,574 First fiscal year in the series	€ 96,437 Gross margin 2023: € 96,437 ▲ 31% vs 2022 (€ 73,574) Favourable step	€ 133,448 Gross margin 2024: € 133,448 ▲ 38% vs 2023 (€ 96,437) Favourable step	€ 37,281 Gross margin 2025: € 37,281 ▼ 72% vs 2024 (€ 133,448) Unfavourable step	▼ 72%
Profit after taxes	€ 45,433 Profit after taxes 2022: € 45,433 First fiscal year in the series	€ 60,720 Profit after taxes 2023: € 60,720 ▲ 34% vs 2022 (€ 45,433) Favourable step	€ 97,002 Profit after taxes 2024: € 97,002 ▲ 60% vs 2023 (€ 60,720) Favourable step	€ 15,684 Profit after taxes 2025: € 15,684 ▼ 84% vs 2024 (€ 97,002) Unfavourable step	▼ 84%
Equity	€ 204,875 Equity 2022: € 204,875 First fiscal year in the series	€ 265,595 Equity 2023: € 265,595 ▲ 30% vs 2022 (€ 204,875) Favourable step	€ 362,597 Equity 2024: € 362,597 ▲ 37% vs 2023 (€ 265,595) Favourable step	€ 378,281 Equity 2025: € 378,281 ▲ 4% vs 2024 (€ 362,597) Favourable step	▲ 4%
Total debts	€ 40,182 Total debts 2022: € 40,182 First fiscal year in the series	€ 38,474 Total debts 2023: € 38,474 ▼ 4% vs 2022 (€ 40,182) Favourable step	€ 25,064 Total debts 2024: € 25,064 ▼ 35% vs 2023 (€ 38,474) Favourable step	€ 25,080 Total debts 2025: € 25,080 Unchanged (€ 25,064) Unfavourable step
Cash	€ 104,184 Cash 2022: € 104,184 First fiscal year in the series	€ 138,338 Cash 2023: € 138,338 ▲ 33% vs 2022 (€ 104,184) Favourable step	€ 311,926 Cash 2024: € 311,926 ▲ 125% vs 2023 (€ 138,338) Favourable step	€ 195,464 Cash 2025: € 195,464 ▼ 37% vs 2024 (€ 311,926) Unfavourable step	▼ 37%
Retained profit	€ 198,678 Retained profit 2022: € 198,678 First fiscal year in the series	€ 259,398 Retained profit 2023: € 259,398 ▲ 31% vs 2022 (€ 198,678) Favourable step	€ 356,400 Retained profit 2024: € 356,400 ▲ 37% vs 2023 (€ 259,398) Favourable step	€ 372,084 Retained profit 2025: € 372,084 ▲ 4% vs 2024 (€ 356,400) Favourable step	▲ 4%
Dividend	€ 17,143 Dividend 2022: € 17,143 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 17,143) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 8 Bank debt 2022: € 8 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 8) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 245,058 Balance sheet total 2022: € 245,058 First fiscal year in the series	€ 304,069 Balance sheet total 2023: € 304,069 ▲ 24% vs 2022 (€ 245,058) Unchanged	€ 387,661 Balance sheet total 2024: € 387,661 ▲ 27% vs 2023 (€ 304,069) Unchanged	€ 436,459 Balance sheet total 2025: € 436,459 ▲ 13% vs 2024 (€ 387,661) Unchanged	▲ 13%

Key figures of MEDRIX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDRIX?

What happened at MEDRIX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Fabienne Boval stepped down as director. NBB
2029 Pierre Trefois stepped down as director. NBB
Aug 20, 2026 New annual accounts for financial year 2025: profit of € 15,684 (▼ 84% vs 2024). filed late Source: NBB ↗
Nov 10, 1993 Start of the company according to the CBE. KBO

In short

From € 45,433 profit in 2022 to € 15,684 profit in 2025.

Paid € 84,110 in corporate taxes since 2022.

Best year ever: 2024, with € 97,002 profit.

Paid out € 17,143 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

MEDRIX

RADIM 50%

It owns 50% of RADIM itself.

Directors

According to the 2025 annual accounts

Fabienne Boval

Director

· until 2029

Pierre Trefois

Director

Also active at: RADIM

· until 2029

Establishments

Establishment units

Physical locations of this company

Registered office

Clos de la Mare aux Loups 14

1330 Rixensart

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

CARDIALI

€ 296,548 gross margin · 2025

CETRIM

€ 327,184 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0451.444.532
VAT number: BE 0451.444.532
Registered office: Clos de la Mare aux Loups 14, 1330 Rixensart
Names & denominations: MEDRIX
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 10 November 1993
Peppol: Active · Active since 11 Dec 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗